共 10 条
[1]
Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17
[2]
Continuous treatment with a combination of estrogen and gestogen-a way of avoiding endometrial stimulation. Staland B. Acta Obstetricia et Gynecologica . 1985
[3]
Bleeding patterns during continuous combined estrogen-progestogen therapy. Marslew U,Riis BJ,Christiansen C. American Journal of Obstetrics and Gynecology . 1991
[4]
Humanendome trial3 β -hydroxysteroiddehydrogenase/ismerasecornlocallyre duceintrinsicestrogen/progestogenicactivityratiosofasteroidaldrug (OrgOD14 ). TangB,MarkiewiczL,KloosterboerHRHJ ,etal. JSteroidBiochemChlolecBiol . 1993
[5]
Psychological and sexual aspects of the menopause and HRT. Pearce MJ,Hawton K. Ballieres Clin Obstet Gynecol . 1996
[6]
Effect of tibolone on postmenopausal bone loss. Tymer J,Chaponan MG,Fogelman I. Osteoporosis International . 1994
[7]
Plasma tiglyceride as a risk factor for cardiovascular disease. Austin MA. Canadian Journal of Cardiology . 1998
[8]
Tibolone and its metabolites: pharmacology, tissue specificity and effects in animal models of tumors. Kloosterboer HJ. Gynecological Endocrinology . 1996
[9]
The incidence of vaginal bleeding with tibolone. Rvmer J,Fogelman I,Chapnlan MG. British Journal of Obstetrics and Gynaecology . 1994
[10]
Livial: a review of clinical studies. Moore RA. Brtish Journal of Obstetrics and Gynaecology . 1999